Discovery of a novel oral, non-RGD pan-αv integrin inhibitor for castration resistant prostate cancer treatment

被引：0
作者：
Gu, Yanlun [1 ,4 ]
Sun, Xiaojiao [2 ]
Dong, Bingqi [3 ]
Song, Song [2 ]
Liu, Zhenming [2 ]
Pang, Xiaocong [1 ,4 ]
Cui, Yimin [1 ,4 ]
机构：
[1] Peking Univ First Hosp, Dept Pharm, Beijing, Peoples R China
[2] Peking Univ, Sch Pharmaceut Sci, Beijing, Peoples R China
[3] Peking Univ First Hosp, Dept Gen Surg, Beijing, Peoples R China
[4] Peking Univ, Inst Clin Pharmacol, Beijing, Peoples R China
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0651
引用
收藏
页码：508 / 509
页数：2
相关论文
共 50 条
  • [41] New treatment standard for patients with non-metastatic castration-resistant prostate cancer
    Alekseev, B. Ya
    ONKOUROLOGIYA, 2018, 14 (03): : 68 - 77
  • [42] Discovery of clinical candidate BMS-986115, an oral pan-Notch inhibitor for the treatment of cancer
    Gavai, Ashvinikumar V.
    Delucca, George
    Norris, Derek
    O'Malley, Daniel
    Zhao, Yufen
    Fink, Brian
    Quesnelle, Claude
    Han, Wen-Ching
    Gill, Patrice
    Vaccaro, Wayne
    Tram Huynh
    Ahuja, Vijay
    Saulnier, Mark
    Frennesson, David
    Tebben, Andrew
    Rampulla, Richard
    Wu, Dauh-Rurng
    Wang, Chunlei
    Zhang, Yingru
    Mathur, Arvind
    Wang, Haiqing
    Moore, Robin
    Yang, Zheng
    Ranasinghe, Asoka
    Tye, Ching Kim
    Su, Ching
    Everlof, Gerry
    Ruan, Qian
    Yarde, Melissa
    Menard, Krista
    Wen, Mei-Li
    Hunt, John
    Vite, Gregory
    Westhouse, Richard
    Lee, Francis
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [43] Tackling non-metastatic castration-resistant prostate cancer: special considerations in treatment
    Anantharaman, Archana
    Small, Eric J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (07) : 625 - 633
  • [44] Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
    Paller, Channing J.
    Antonarakis, Emmanuel S.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2011, 5 : 117 - 124
  • [45] Characteristics and Treatment Patterns for Non-Metastatic Castration Resistant Prostate Cancer Patients in Japan
    Shah, Ruchitbhai
    Ledesma, Dianne
    Ikeme, Shelly
    Botteman, Marc
    Waldeck, Reg
    ANNALS OF ONCOLOGY, 2019, 30
  • [46] Discovery of CFG920, a dual CYP17/CYP11B2 inhibitor, for the treatment of castration resistant prostate cancer
    Gaul, Christoph
    Mistry, Prakash
    Moebitz, Henrik
    Perrone, Mark
    Gruenenfelder, Bjoern
    Guerreiro, Nelson
    Hackl, Wolfgang
    Wessels, Peter
    Berger, Estelle
    Bock, Mark
    Sengupta, Saumitra
    Rao, Venkateshwar
    Ramachandra, Murali
    Antony, Thomas
    Narayanan, Kishore
    Dodheri, Samiulla
    Basavaraju, Aravind
    Chelur, Shekar
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [47] Discovery of a novel AR/HDAC6 dual inhibitor for prostate cancer treatment
    Zhou, Maojun
    Zheng, Hao
    Li, Yubin
    Huang, Huichao
    Min, Xiaoli
    Dai, Shuyan
    Zhou, Wenqiang
    Chen, Zhuchu
    Xu, Guangyu
    Chen, Yongheng
    AGING-US, 2021, 13 (05): : 6982 - 6998
  • [48] HSK38008: An oral AR-V7 degrader for metastatic castration-resistant prostate cancer
    Wang, Ju
    Qian, Meilin
    Yan, Pangke
    Li, Linli
    Zhang, Chen
    Yu, Yan
    Tao, Lihua
    Tang, Pingming
    Liao, Yuting
    Chen, Xiaogang
    Cheng, Xinfan
    Xu, Jinxiong
    Wan, Xuemei
    Deng, Luchan
    Dong, Hongjiao
    Zhang, Haixian
    He, Maotao
    CANCER RESEARCH, 2023, 83 (08)
  • [49] Discovery of dual-functional AKR1C3 inhibitors and AR antagonists as a novel treatment for castration resistant prostate cancer
    Wangtrakuldee, Phumvadee
    Adeniji, Adegoke
    Tamae, Daniel
    Zang, Tianzhu
    Twenter, Barry
    Estrada, Michelle
    Winkler, Jeffrey
    Penning, Trevor
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [50] Characterisation of CCS1477: A novel small molecule inhibitor of p300/CBP for the treatment of castration resistant prostate cancer.
    Pegg, Neil
    Brooks, Nigel
    Worthington, Jenny
    Young, Barbara
    Prosser, Amy
    Lane, Jordan
    Taddei, David
    Brown, Richard
    Harbottle, Gareth
    Shannon, Jonathan
    Paoletta, Silvia
    Knudsen, Karen E.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345